Alkem Labs gets EIR from USFDA

Alkem Labs gets EIR from USFDA for St Louis facility in US.

255
USFDA
Picture: Pixabay

Alkem Labs gets EIR from USFDA

Drug firm Alkem Laboratories has received establishment inspection report (EIR) from United States Food and Drug Administration (FDA) for St Louis facility in US.

The company added that the inspection has now been closed by the regulator.

Also read: Dr. Reddy’s receives EIR from USFDA

Inspection

The inspection was conducted by the US FDA from January 27 to February 6, 2020, the company said in an earlier filing.

Alkem Laboratories is a multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical generics, formulations and neutraceutricals in India.

The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.